Bonnot A, Corio M, Bouc A M, Viala D
Laboratoire des Neurosciences de la Motricité, UMR-CNRS 5807, Talence, France.
J Physiol Paris. 1998 Feb;92(1):5-15. doi: 10.1016/S0928-4257(98)80017-X.
Although AMPA receptors are known to be widely involved in excitatory synaptic neurotransmission at the spinal level, very little is known about their role in modulating motor activity in mammals. In curarized decerebrate or spinalized rabbit preparations, fictive locomotion was monitored on hindlimb nerves after either activation or blockade of AMPA receptors. In decerebrate preparations, the administration of the antagonist, NBQX (3.5 mg/kg i.p.) or the agonist, AMPA (0.5 mg/kg i.v.) produced, in both cases, a depression of locomotor activities induced by stimulation of cutaneous afferents (evoked locomotor activity). This potent effect was transient with AMPA (recovery after 20 min) and followed by the occurrence of spontaneous locomotor sequences, while no recovery was observed with NBQX treatment. In spinal preparations where a continuous 'spontaneous' locomotor activity resulted from the pharmacological activation of noradrenergic descending pathways (nialamide-DOPA pretreatment), the same drugs injected at higher doses (5 mg/kg NBQX i.p. and 1 mg/kg AMPA i.v.) only weakly affected the frequency of 'spontaneous' and evoked locomotor bursts while they exerted inhibitory and facilitatory effects on the burst amplitude respectively. The results suggest that AMPA receptors are involved at spinal level: 1) in direct mediation of cutaneous afferent excitatory effects on the posterior locomotor generators (pLG); 2) in indirect mediation of a supraspinal descending inhibition controlling, likely presynaptically, the cutaneous afferent activation; and 3) in transmission to motoneurons of the output signals from the pLG. Finally, tight spinal interactions between potent descending noradrenergic pathways and spinal AMPA neurotransmission were disclosed.
尽管已知α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体广泛参与脊髓水平的兴奋性突触神经传递,但关于它们在调节哺乳动物运动活动中的作用却知之甚少。在箭毒化的去大脑或脊髓化兔制备物中,在激活或阻断AMPA受体后,对后肢神经的虚构运动进行监测。在去大脑制备物中,给予拮抗剂2,3-二氧-6-硝基-1,2,3,4-四氢苯并喹喔啉(NBQX,腹腔注射3.5毫克/千克)或激动剂AMPA(静脉注射0.5毫克/千克),在两种情况下,均会抑制由皮肤传入刺激诱导的运动活动(诱发运动活动)。这种强效作用对AMPA来说是短暂的(20分钟后恢复),随后会出现自发运动序列,而NBQX处理后未观察到恢复。在脊髓制备物中,去甲肾上腺素能下行通路的药理学激活(尼亚酰胺-多巴预处理)导致持续的“自发”运动活动,以更高剂量注射相同药物(腹腔注射5毫克/千克NBQX和静脉注射1毫克/千克AMPA)只会轻微影响“自发”和诱发运动爆发的频率,同时它们分别对爆发幅度产生抑制和促进作用。结果表明,AMPA受体在脊髓水平参与:1)直接介导皮肤传入对后运动发生器(pLG)的兴奋性作用;2)间接介导可能在突触前控制皮肤传入激活的脊髓上抑制;3)将pLG的输出信号传递给运动神经元。最后,揭示了强大的下行去甲肾上腺素能通路与脊髓AMPA神经传递之间紧密的脊髓相互作用。